MCMV3068A
- Generic Name
- MCMV3068A
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- I4SA959J1V
- Background
MCMV3068A is an anticytomegalovirus monoclonal IgG1 antibody used in combination with MCMV5322A to form RG7667.
- Associated Conditions
- -
- Associated Therapies
- -
A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-12-20
- Last Posted Date
- 2017-03-08
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 122
- Registration Number
- NCT01753167
- Locations
- 🇫🇷
Hopital Pellegrin-CHU de Bordeaux; Service de Neurologie, Bordeaux, France
🇫🇷Hopital Necker, Paris, France
🇫🇷Hopital Rangueil; Gastro Enterologie Et Nutrition, Toulouse, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath